Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Molecular modeling and docking studies of the oxytocin receptor.

Antobreh G, Enyedy I, Ravna AW.

Future Med Chem. 2018 Jan;10(2):135-155. doi: 10.4155/fmc-2017-0078. Epub 2017 Dec 13.

PMID:
29235904
2.

Comparative molecular dynamics simulations of mitogen-activated protein kinase-activated protein kinase 5.

Lindin I, Wuxiuer Y, Ravna AW, Moens U, Sylte I.

Int J Mol Sci. 2014 Mar 19;15(3):4878-902. doi: 10.3390/ijms15034878.

3.

Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5).

Lindin I, Wuxiuer Y, Kufareva I, Abagyan R, Moens U, Sylte I, Ravna AW.

Theor Biol Med Model. 2013 Sep 14;10:56. doi: 10.1186/1742-4682-10-56.

4.

Homology modeling of transporter proteins (carriers and ion channels).

Ravna AW, Sylte I.

Methods Mol Biol. 2012;857:281-99. doi: 10.1007/978-1-61779-588-6_12. Review.

PMID:
22323226
5.

The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism.

Hessvik NP, Bakke SS, Smith R, Ravna AW, Sylte I, Rustan AC, Thoresen GH, Kase ET.

J Steroid Biochem Mol Biol. 2012 Feb;128(3-5):154-64. doi: 10.1016/j.jsbmb.2011.10.006. Epub 2011 Oct 25.

PMID:
22051079
6.

[ABC transporters' impact on effect and metabolism of drugs].

Slåtsve AM, Ravna AW, Lyså RA, Sager G.

Tidsskr Nor Laegeforen. 2011 Jun 3;131(11):1084-7. doi: 10.4045/tidsskr.10.0675. Review. Norwegian.

7.

Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations.

Gabrielsen M, Ravna AW, Kristiansen K, Sylte I.

J Mol Model. 2012 Mar;18(3):1073-85. doi: 10.1007/s00894-011-1133-1. Epub 2011 Jun 14.

8.

Cellular efflux of cAMP and cGMP - a question about selectivity.

Sager G, Ravna AW.

Mini Rev Med Chem. 2009 Jul;9(8):1009-13. Review.

PMID:
19601896
9.

Molecular modeling studies of ABC transporters involved in multidrug resistance.

Ravna AW, Sager G.

Mini Rev Med Chem. 2009 Feb;9(2):186-93. Review.

PMID:
19200023
10.

Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.

Mavel S, Vercouillie J, Garreau L, Raguza T, Ravna AW, Chalon S, Guilloteau D, Emond P.

Bioorg Med Chem. 2008 Oct 1;16(19):9050-5. doi: 10.1016/j.bmc.2008.08.002. Epub 2008 Aug 6.

PMID:
18793858
11.

Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4).

Ravna AW, Sager G.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3481-3. doi: 10.1016/j.bmcl.2008.05.047. Epub 2008 May 16.

PMID:
18513968
12.

A molecular model of a putative substrate releasing conformation of multidrug resistance protein 5 (MRP5).

Ravna AW, Sylte I, Sager G.

Eur J Med Chem. 2008 Nov;43(11):2557-67. doi: 10.1016/j.ejmech.2008.01.015. Epub 2008 Jan 25.

PMID:
18313803
13.

A homology model of SERT based on the LeuT(Aa) template.

Ravna AW, Jaronczyk M, Sylte I.

Bioorg Med Chem Lett. 2006 Nov 1;16(21):5594-7. Epub 2006 Aug 17.

PMID:
16919451
14.
15.

Putative drug binding conformations of monoamine transporters.

Ravna AW, Sylte I, Kristiansen K, Dahl SG.

Bioorg Med Chem. 2006 Feb 1;14(3):666-75. Epub 2005 Oct 10.

PMID:
16216517
16.

Structures and models of transporter proteins.

Dahl SG, Sylte I, Ravna AW.

J Pharmacol Exp Ther. 2004 Jun;309(3):853-60. Epub 2004 Feb 26. Review.

PMID:
14988415
17.

Molecular model of the neural dopamine transporter.

Ravna AW, Sylte I, Dahl SG.

J Comput Aided Mol Des. 2003 May-Jun;17(5-6):367-82.

PMID:
14635728
18.

Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.

Ravna AW, Sylte I, Dahl SG.

J Pharmacol Exp Ther. 2003 Oct;307(1):34-41. Epub 2003 Aug 27.

PMID:
12944499

Supplemental Content

Loading ...
Support Center